Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity

Journal of Clinical Investigation

Volumn 110, Issue 3, 2002, Pages 361-369

  Saegusa, Kaoru ^a   Ishimaru, Naozumi ^a   Yanagi, Kumiko ^a   Arakaki, Rieko ^a   Ogawa, Kouichi ^a   Saito, Ichiro ^a   Katunuma, Nobuhiko ^b   Hayashi, Yoshio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CATHEPSIN B; CATHEPSIN L; CATHEPSIN S; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; DOSE RESPONSE; FEMALE; FLOW CYTOMETRY; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALIVARY GLAND; SJOEGREN SYNDROME;

EID: 0036329099     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0214682     Document Type: Article

References (53)

1. Sjögren's syndrome. Proposed criteria for classification
2. Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen
3. Diagnostic criteria and immunopathogenesis of Sjögren's syndrome: Implications for therapy
4. A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice
5. Effector mechanism of experimental autoimmune sialadenitis in the mouse model for primary Sjögren's syndrome
6. Estrogen dediciency accelerates autoimmune exocrinopathy in murine Sjögren's syndrome through Fas-mediated apoptosis
7. Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis
8. Mechanisms of neonatal tolerance induced in an animal model for primary Sjögren's syndrome by intravenous administration of autoantigen
9. low T cell subset prevents autoimmune exocrinopathy in murine Sjögren's syndrome
10. Identification of α-fodrin as a candidate autoantigen in primary Sjögren's syndrome
11. Antigen presentation. Getting peptides onto MHC class II molecules
12. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation
13. How MHC class II molecules acquire peptide cargo: Biosynthesis and trafficking through the endocytic pathway
14. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain
15. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes
16. Role for intracellular proteases in the processing and transport of class II HLA antigens
17. Inhibition by leupeptin and antipain of the intracellular proteolysis of Ii
18. Structural analysis of proteolytic products of MHC class II-invariant chain complexes generated in vivo
19. Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistant ab heterodimers in endosomes
20. Cathepsin B cleavage of Ii from MHC α- and β-chains
21. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L
22. Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease
23. Human cathepsin S: Chromosomal localization, gene structure, and tissue distribution
24. Degradation of mouse Ii: Roles of cathepsins S and D and the influence of allelic polymorphism
25. Novel epoxysuccinyl peptides: A selective inhibitor of cathepsin B, in vivo
26. Novel epoxysuccinyl peptides: Selective inhibitors of cathepsin B, in virro
27. Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vivo and in vitro
28. Participation of cathepsin B in processing of antigen presentation to MHC class II
29. A new mutation involving the sublingual gland in NFS/N mice: Partially arrested mucous cell differentiation
30. Specific assay method for the activities of cathepsin L-type cysteine proteinases
31. Induction of experimental autoallergic sialadenitis
32. Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands
33. Fas ligand-mediated exocrinopathy resembling Sjögren's syndrome in mice transgenic for IL-10
34. Epithelial cell expressing aberrant MHC class II determinants can present antigen to cloned human T cells
35. HLA class II induction in human islet cells by interferon-γ plus tumor necrosis factor or lymphoroxin
36. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading
37. Bioenergetics of immune functions: Fundamental and therapeutic aspects
38. TNF is here to stay
39. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity
40. Expression of histocompatibility antigen HLA-DR by salivary gland epithelial cells in Sjögren's syndrome
41. Class II MHC antigen expression on epithelial cells of salivary glands from patients with Sjögren's syndrome
42. Class II antigen expression by lacrimal epithelial cells. An updated working hypothesis for antigen presentation by epithelial cells
43. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding
44. Stimulation of T cell by antigen-presenting cells is kinetically controlled by antigenic peptide binding to major histocompatibility complex class II molecules
45. Early biochemical signals arise from low-affinity T cell receptor-ligand reactions at the cell-cell interface
46. Specific T cell recognition of kinetic isomers in the binding of peptide to class II MHC
47. Degradation of mouse invariant chain: Roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism
48. Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation
49. Cathepsin L: Critical role in Ii degradation and CD4 T cell selection in the thymus
50. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice
51. Cathepsin S required for normal MHC class II pepride loading and germinal center development
52. Cathepsin S activity regulates antigen presentation and immunity
53. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages